nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—SLC22A11—Doxycycline—malaria	0.185	0.2	CbGbCtD
Phenylbutazone—SLC22A8—Doxycycline—malaria	0.107	0.116	CbGbCtD
Phenylbutazone—SLC22A6—Doxycycline—malaria	0.0748	0.0808	CbGbCtD
Phenylbutazone—SLC22A8—Quinidine—malaria	0.0641	0.0693	CbGbCtD
Phenylbutazone—PTGS2—Dapsone—malaria	0.052	0.0562	CbGbCtD
Phenylbutazone—CYP3A4—Clindamycin—malaria	0.0458	0.0496	CbGbCtD
Phenylbutazone—CYP2C9—Sulfadiazine—malaria	0.0453	0.049	CbGbCtD
Phenylbutazone—CYP2C9—Pyrimethamine—malaria	0.0453	0.049	CbGbCtD
Phenylbutazone—PTGS1—Dapsone—malaria	0.0439	0.0475	CbGbCtD
Phenylbutazone—CYP2C9—Artemether—malaria	0.0385	0.0416	CbGbCtD
Phenylbutazone—CYP2C9—Proguanil—malaria	0.0362	0.0392	CbGbCtD
Phenylbutazone—CYP3A4—Sulfadiazine—malaria	0.0263	0.0285	CbGbCtD
Phenylbutazone—CYP2C9—Quinine—malaria	0.0233	0.0252	CbGbCtD
Phenylbutazone—CYP3A4—Artemether—malaria	0.0224	0.0242	CbGbCtD
Phenylbutazone—CYP3A4—Proguanil—malaria	0.021	0.0228	CbGbCtD
Phenylbutazone—CYP2C9—Quinidine—malaria	0.0205	0.0222	CbGbCtD
Phenylbutazone—CYP3A4—Doxycycline—malaria	0.02	0.0216	CbGbCtD
Phenylbutazone—CYP2C9—Dapsone—malaria	0.0177	0.0191	CbGbCtD
Phenylbutazone—CYP3A4—Quinine—malaria	0.0136	0.0147	CbGbCtD
Phenylbutazone—PTGIS—endothelium—malaria	0.012	0.204	CbGeAlD
Phenylbutazone—CYP3A4—Quinidine—malaria	0.0119	0.0129	CbGbCtD
Phenylbutazone—CYP3A4—Dapsone—malaria	0.0103	0.0111	CbGbCtD
Phenylbutazone—PTGIS—liver—malaria	0.00305	0.0519	CbGeAlD
Phenylbutazone—SLC22A11—kidney—malaria	0.0027	0.0459	CbGeAlD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.0026	0.157	CbGpPWpGaD
Phenylbutazone—PTGIS—brain—malaria	0.00242	0.0412	CbGeAlD
Phenylbutazone—SLC22A11—digestive system—malaria	0.00229	0.039	CbGeAlD
Phenylbutazone—PTGS1—endothelium—malaria	0.00224	0.0382	CbGeAlD
Phenylbutazone—CYP2C9—blood plasma—malaria	0.00218	0.0372	CbGeAlD
Phenylbutazone—PTGS2—endothelium—malaria	0.00214	0.0365	CbGeAlD
Phenylbutazone—PTGS1—blood plasma—malaria	0.00199	0.0339	CbGeAlD
Phenylbutazone—PTGS2—blood plasma—malaria	0.0019	0.0324	CbGeAlD
Phenylbutazone—SLC22A8—hematopoietic system—malaria	0.00186	0.0316	CbGeAlD
Phenylbutazone—SLC22A11—liver—malaria	0.0017	0.029	CbGeAlD
Phenylbutazone—CYP3A4—blood plasma—malaria	0.00166	0.0283	CbGeAlD
Phenylbutazone—SLC22A8—kidney—malaria	0.00152	0.0259	CbGeAlD
Phenylbutazone—SLC22A6—brain—malaria	0.00127	0.0217	CbGeAlD
Phenylbutazone—SLC22A8—blood—malaria	0.00123	0.0209	CbGeAlD
Phenylbutazone—CYP2C9—hematopoietic system—malaria	0.00121	0.0205	CbGeAlD
Phenylbutazone—PTGS1—hematopoietic system—malaria	0.0011	0.0188	CbGeAlD
Phenylbutazone—PTGS2—hematopoietic system—malaria	0.00105	0.0179	CbGeAlD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—HPGDS—malaria	0.000939	0.0566	CbGpPWpGaD
Phenylbutazone—CYP3A4—hematopoietic system—malaria	0.00092	0.0157	CbGeAlD
Phenylbutazone—PTGS1—kidney—malaria	0.000903	0.0154	CbGeAlD
Phenylbutazone—PTGS2—kidney—malaria	0.000863	0.0147	CbGeAlD
Phenylbutazone—CYP2C9—digestive system—malaria	0.000839	0.0143	CbGeAlD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.0008	0.0481	CbGpPWpGaD
Phenylbutazone—CYP2C9—blood—malaria	0.000799	0.0136	CbGeAlD
Phenylbutazone—PTGS1—digestive system—malaria	0.000766	0.013	CbGeAlD
Phenylbutazone—SLC22A8—brain—malaria	0.000763	0.013	CbGeAlD
Phenylbutazone—CYP3A4—kidney—malaria	0.000754	0.0128	CbGeAlD
Phenylbutazone—PTGS2—digestive system—malaria	0.000732	0.0125	CbGeAlD
Phenylbutazone—PTGS1—blood—malaria	0.00073	0.0124	CbGeAlD
Phenylbutazone—PTGS2—blood—malaria	0.000698	0.0119	CbGeAlD
Phenylbutazone—PTGS2—bone marrow—malaria	0.000675	0.0115	CbGeAlD
Phenylbutazone—CYP3A4—digestive system—malaria	0.00064	0.0109	CbGeAlD
Phenylbutazone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000635	0.0382	CbGpPWpGaD
Phenylbutazone—CYP2C9—liver—malaria	0.000625	0.0106	CbGeAlD
Phenylbutazone—CYP3A4—blood—malaria	0.00061	0.0104	CbGeAlD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.00056	0.0337	CbGpPWpGaD
Phenylbutazone—PTGS2—liver—malaria	0.000545	0.00929	CbGeAlD
Phenylbutazone—CYP3A4—liver—malaria	0.000477	0.00812	CbGeAlD
Phenylbutazone—PTGS1—brain—malaria	0.000453	0.00771	CbGeAlD
Phenylbutazone—PTGS2—brain—malaria	0.000433	0.00737	CbGeAlD
Phenylbutazone—PTGIS—Biological oxidations—HPGDS—malaria	0.00035	0.021	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—malaria	0.000325	0.0196	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—HBB—malaria	0.000303	0.0183	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000291	0.0175	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000289	0.0174	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000258	0.0155	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—KDR—malaria	0.000248	0.0149	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000245	0.0148	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000245	0.0148	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—FAS—malaria	0.000242	0.0146	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000241	0.0145	CbGpPWpGaD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000229	0.0138	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000222	0.0134	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000219	0.0132	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000213	0.0128	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000185	0.0111	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.000169	0.0102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000152	0.00914	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC4A1—malaria	0.000148	0.0089	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—malaria	0.000147	0.00886	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000144	0.0087	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000142	0.00853	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000141	0.0085	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000138	0.00829	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000137	0.00822	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—DHODH—malaria	0.000137	0.00822	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000134	0.00808	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000134	0.00806	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000129	0.00775	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000123	0.00742	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.000119	0.00715	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000117	0.00704	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC4A1—malaria	0.000116	0.00699	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000115	0.00694	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000114	0.00689	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC4A1—malaria	0.000113	0.00679	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—DECR1—malaria	0.000109	0.00657	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—HPGDS—malaria	0.000107	0.00647	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PKLR—malaria	0.000105	0.00632	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—malaria	0.000103	0.00619	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—HBB—malaria	9.87e-05	0.00594	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—malaria	9.54e-05	0.00574	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—malaria	9.43e-05	0.00568	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC4A1—malaria	9.41e-05	0.00567	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—G6PD—malaria	9.36e-05	0.00564	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PKLR—malaria	8.8e-05	0.0053	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	8.77e-05	0.00528	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	8.33e-05	0.00501	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—malaria	8.3e-05	0.005	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	7.85e-05	0.00472	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—G6PD—malaria	7.84e-05	0.00472	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CD36—malaria	7.74e-05	0.00466	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—malaria	7.58e-05	0.00456	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	7.53e-05	0.00453	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	7.4e-05	0.00445	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	6.96e-05	0.00419	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL4—malaria	6.93e-05	0.00417	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IFNG—malaria	6.67e-05	0.00402	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—DHFR—malaria	6.62e-05	0.00399	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—HPGDS—malaria	5.98e-05	0.0036	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	5.98e-05	0.0036	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—malaria	5.95e-05	0.00358	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	5.76e-05	0.00347	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TLR4—malaria	5.74e-05	0.00346	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—HPGDS—malaria	5.65e-05	0.0034	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—DHFR—malaria	5.55e-05	0.00334	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—ICAM1—malaria	5.51e-05	0.00331	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SCARB1—malaria	5.49e-05	0.0033	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—NOS2—malaria	5.46e-05	0.00329	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	5.39e-05	0.00324	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CD4—malaria	5.31e-05	0.0032	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IFNG—malaria	5.3e-05	0.00319	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—malaria	4.73e-05	0.00284	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	4.35e-05	0.00262	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—malaria	4.32e-05	0.0026	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—DHODH—malaria	4.2e-05	0.00253	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IFNG—malaria	4.19e-05	0.00252	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.13e-05	0.00248	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	3.96e-05	0.00238	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.79e-05	0.00228	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—malaria	3.74e-05	0.00225	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—HPGDS—malaria	3.73e-05	0.00224	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—malaria	3.72e-05	0.00224	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC4A1—malaria	3.57e-05	0.00215	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—malaria	3.49e-05	0.0021	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CD36—malaria	3.45e-05	0.00207	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—malaria	3.43e-05	0.00206	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS2—malaria	3.38e-05	0.00204	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—DECR1—malaria	3.35e-05	0.00202	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—DHODH—malaria	3.33e-05	0.00201	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.28e-05	0.00197	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HBB—malaria	3.03e-05	0.00183	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.01e-05	0.00181	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC4A1—malaria	2.83e-05	0.00171	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—malaria	2.77e-05	0.00167	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—malaria	2.71e-05	0.00163	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PKLR—malaria	2.7e-05	0.00163	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—DECR1—malaria	2.66e-05	0.0016	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PKLR—malaria	2.56e-05	0.00154	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD4—malaria	2.51e-05	0.00151	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—G6PD—malaria	2.41e-05	0.00145	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HBB—malaria	2.41e-05	0.00145	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	2.38e-05	0.00143	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—G6PD—malaria	2.28e-05	0.00138	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—DHODH—malaria	2.21e-05	0.00133	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—malaria	2.19e-05	0.00132	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.17e-05	0.00131	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PKLR—malaria	2.15e-05	0.00129	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.99e-05	0.0012	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—G6PD—malaria	1.91e-05	0.00115	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	1.89e-05	0.00114	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC4A1—malaria	1.88e-05	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.84e-05	0.00111	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HPGDS—malaria	1.84e-05	0.00111	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—DECR1—malaria	1.76e-05	0.00106	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—DHFR—malaria	1.71e-05	0.00103	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SCARB1—malaria	1.69e-05	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—DHFR—malaria	1.62e-05	0.000973	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HBB—malaria	1.59e-05	0.00096	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HPGDS—malaria	1.46e-05	0.000878	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DHODH—malaria	1.45e-05	0.000876	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PKLR—malaria	1.42e-05	0.000856	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—malaria	1.35e-05	0.000816	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—DHFR—malaria	1.35e-05	0.000815	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SCARB1—malaria	1.34e-05	0.000806	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—G6PD—malaria	1.27e-05	0.000763	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.25e-05	0.000753	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC4A1—malaria	1.24e-05	0.000745	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DECR1—malaria	1.16e-05	0.0007	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD36—malaria	1.06e-05	0.000638	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HBB—malaria	1.05e-05	0.000633	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HPGDS—malaria	9.66e-06	0.000582	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PKLR—malaria	9.37e-06	0.000564	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—DHFR—malaria	8.96e-06	0.00054	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SCARB1—malaria	8.87e-06	0.000534	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD36—malaria	8.41e-06	0.000506	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—G6PD—malaria	8.36e-06	0.000503	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—malaria	8.25e-06	0.000497	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HPGDS—malaria	6.37e-06	0.000384	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—malaria	6.11e-06	0.000368	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DHFR—malaria	5.91e-06	0.000356	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SCARB1—malaria	5.85e-06	0.000352	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD36—malaria	5.57e-06	0.000335	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD36—malaria	3.67e-06	0.000221	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—malaria	3.31e-06	0.000199	CbGpPWpGaD
